Intronix Technologies Corporation

Intronix Technologies Corporation designs and produces software for patients and clinicians to help manage chronic pain; As well as our well known hand-held “Myoguide” EMG/ STIM injection guidance device for use with toxin and neurolytic drugs used to help manage patients with spasticity and pain. Myoguide was designed to be continuously upgradable within the scope of its operation, ensuring our devices can evolve with new clinical demands and technology.

Intronix “I-engage” and “I-quantify” apps are designed to work in harmony, to create a synergistic method of assessing ongoing quality of life and chronic pain assessments. Communication between patients and clinicians through a secure cloud, ensure up to date knowledge of patient state. Ongoing graphic records of quantified patient data and in-office indexes/ questionnaires are available at a glance, contributing to tracking patient state as well as treatment outcomes.

Intronix products enable clinicians to improve diagnosis, treatment planning, boost treatment efficacy and provide accurate follow-up assessment of movement disorders, myofascial pain, spasticity, and fibromyalgia.

Company’s Keywords:

medical devices